| Ytd | 1.76% | |
| 1y | 97.14% |
| Open | 14.49 | Prev Close | 14.49 | Low | 14.49 | High | 14.50 | Mkt Cap | 4.55B |
| Vol | 0.00 | Avg Vol | 4.15M | EPS | -0.09 | P/E | -161.00 | Forward P/E | 30.49 |
| Beta | 0.48 | Short Ratio | 6.36 | Inst. Own | 104.39% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-04 | 50-d Avg | 14.40 | 200-d Avg | 10.88 | 1yr Est | 14.50 |
FOLD News
BioMarin Pharmaceutical remains a "Strong Buy," driven by pipeline progress, strategic acquisitions,
Amicus Therapeutics targets rare genetic diseases with proprietary therapies and a pipeline of treat
BioMarin (BMRN) has declined over 12% since January 2025, despite prior optimism. The investment the
SG Americas Securities LLC boosted its holdings in Amicus Therapeutics, Inc. (NASDAQ: FOLD) by 53.2%
Capricorn Fund Managers Ltd bought a new stake in Amicus Therapeutics, Inc. (NASDAQ: FOLD) during th
NEW YORK--(BUSINESS WIRE)--LSTA, the trade association for the U.S. corporate lending market, today
Avoro Capital Advisors LLC reduced its stake in Amicus Therapeutics, Inc. (NASDAQ: FOLD) by 16.5% in
Microsoft filed on Tuesday a proposed brief in support of Anthropic's lawsuit asking the court to
FOLD's Q4 earnings miss, but revenues beat estimates on strong Galafold and Pombiliti sales. The com
Granite Investment Partners LLC cut its stake in Amicus Therapeutics, Inc. (NASDAQ: FOLD) by 2.0% in
2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position of $294M, a $44M Increase in
Let's take a closer look at what awaits Bausch Health, Amicus Therapeutics, BioMarin Pharmaceutical,
FOLD heads into Q4 earnings with Galafold driving growth and Pombiliti + Opfolda aiding the top line
PRINCETON, N.J., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), today announc
Amicus and Rigel target rare diseases, but a pending BioMarin buyout and growing drug sales set up d
Amicus Therapeutics, Inc. (NASDAQ: FOLD - Get Free Report) CEO Bradley Campbell sold 75,000 shares o
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t
Pre-Market Stock Futures: The futures are trading higher this morning, following a solid bounce-back
Amicus stock soars 135.8% in six months as demand for marketed products grows. The company is set to
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a
On Friday, 1043 companies hit new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday
Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
Stocks Which Set New 52-Week Low Yesterday, October 23rd